Halozyme Therapeutics, Inc. (HALO)
106.54
+1.20
(+1.13%)
USD |
NASDAQ |
Aug 31, 16:00
106.30
-0.24
(-0.23%)
After-Hours: 18:43
Halozyme Therapeutics Net Income (TTM) : 413.60M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 413.60M |
| March 31, 2026 | 348.84M |
| December 31, 2025 | 316.89M |
| September 30, 2025 | 595.49M |
| June 30, 2025 | 557.28M |
| March 31, 2025 | 485.36M |
| December 31, 2024 | 444.09M |
| September 30, 2024 | 392.47M |
| June 30, 2024 | 337.29M |
| March 31, 2024 | 318.80M |
| December 31, 2023 | 281.59M |
| September 30, 2023 | 253.91M |
| June 30, 2023 | 233.70M |
| March 31, 2023 | 181.64M |
| December 31, 2022 | 202.13M |
| September 30, 2022 | 211.20M |
| June 30, 2022 | 366.15M |
| March 31, 2022 | 434.92M |
| December 31, 2021 | 402.71M |
| September 30, 2021 | 409.10M |
| June 30, 2021 | 228.72M |
| March 31, 2021 | 163.08M |
| December 31, 2020 | 129.08M |
| September 30, 2020 | 21.52M |
| June 30, 2020 | -39.70M |
| Date | Value |
|---|---|
| March 31, 2020 | -80.14M |
| December 31, 2019 | -72.24M |
| September 30, 2019 | -39.97M |
| June 30, 2019 | -42.80M |
| March 31, 2019 | -51.07M |
| December 31, 2018 | -80.33M |
| September 30, 2018 | 45.68M |
| June 30, 2018 | 76.28M |
| March 31, 2018 | 68.41M |
| December 31, 2017 | 62.97M |
| September 30, 2017 | -88.30M |
| June 30, 2017 | -119.99M |
| March 31, 2017 | -116.10M |
| December 31, 2016 | -103.02M |
| September 30, 2016 | -71.32M |
| June 30, 2016 | -66.83M |
| March 31, 2016 | -36.94M |
| December 31, 2015 | -32.23M |
| September 30, 2015 | -41.82M |
| June 30, 2015 | -37.64M |
| March 31, 2015 | -56.94M |
| December 31, 2014 | -68.38M |
| September 30, 2014 | -85.09M |
| June 30, 2014 | -84.10M |
| March 31, 2014 | -90.74M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Incyte Corp. | 1.612B |
| AVITA Medical, Inc. | -43.08M |
| Neurocrine Biosciences, Inc. | 705.50M |
| Iovance Biotherapeutics, Inc. | -289.52M |
| Editas Medicine, Inc. | -73.95M |